Trinity Legacy Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$285K Buy
+3,331
New +$326K 0.06% 106
2023
Q2
– Sell
-31,744
Closed -$2.36M – 86
2023
Q1
$2.36M Buy
31,744
+866
+3% +$72.6K 0.89% 39
2022
Q4
$2.88M Buy
30,878
+1,946
+7% +$188K 1.15% 36
2022
Q3
$2.76M Buy
28,932
+3,341
+13% +$331K 1.18% 35
2022
Q2
$2.42M Sell
25,591
-3,469
-12% -$339K 0.94% 37
2022
Q1
$2.94M Buy
29,060
+2,385
+9% +$251K 0.99% 36
2021
Q4
$2.75M Buy
26,675
+830
+3% +$76.7K 0.93% 36
2021
Q3
$2.19M Buy
25,845
+1,279
+5% +$107K 0.79% 39
2021
Q2
$2.01M Buy
24,566
+5,935
+32% +$486K 0.74% 39
2021
Q1
$1.41M Buy
+18,631
New +$1.36M 0.56% 41

Other funds holding CVS

Trinity Legacy Partners's CVS Position: Q3 2026 in Review

Trinity Legacy Partners opened a new position in CVS Health (CVS) in Q3 2026: 3,331 shares worth $285K. The stake represents 0.06% of the portfolio and ranks #106 among its holdings. This is a return to the name: Trinity Legacy Partners previously reported a position in CVS as recently as Q1 2023.

Trinity Legacy Partners first reported a position in CVS in Q1 2021 and has held it in 10 quarters since. The position peaked at $2.94M in Q1 2022. 1,996 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Trinity Legacy Partners held 3,331 shares of CVS Health worth $285K as of Q3 2026.
  • CVS Health was a new Trinity Legacy Partners position in Q3 2026.
  • CVS Health made up 0.06% of Trinity Legacy Partners's portfolio in Q3 2026, its #106 holding.
  • Trinity Legacy Partners first reported a position in CVS Health in Q1 2021 and has held it in 10 quarters since.
  • Trinity Legacy Partners's CVS Health position peaked at $2.94M in Q1 2022.
  • 1,996 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Trinity Legacy Partners's 13F filing for Q3 2026, filed 16 Nov 2026.